Moexa Pharmaceuticals
Manufacturing · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
375 Morgan Ln Ste 204, West Haven, Conne...Website
www.moexa.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Moexa Pharmaceuticals
Moexa specializes in the development of first-in-class small molecule SMAD signaling therapeutics with a focus on anti-cancer and anti-fibrosis treatments. With dominant global intellectual property rights secured for these therapies, the company addresses a market valued at over $125 billion across major global markets including the US, EU, China, and India. Moexa's offerings include combination therapies and preclinical studies that demonstrate the efficacy of these small molecules in enhancing therapeutic outcomes. The company's strategic focus on AI-driven drug discovery further supports its innovative approach to developing advanced therapies.Explore more
Moexa Pharmaceuticals Org Chart
TL
Founder & Director & Director, Technical Plan...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Moexa Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Moexa Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Moexa Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Moexa Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Moexa Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Moexa Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at Moexa Pharmaceuticals
Check out if Moexa Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on Moexa Pharmaceuticals recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Moexa Pharmaceuticals
Compare insights from companies similar to Moexa Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Moexa Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Moexa Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Moexa Pharmaceuticals.
Moexa Pharmaceuticals Tech Stack
A closer look at the technologies used by Moexa Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Moexa Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Moexa specializes in the development of first-in-class small molecule SMAD signaling therapeutics with a focus on anti-cancer and anti-fibrosis treatments. With dominant global intellectual property rights secured for these therapies, the company addresses a market valued at over $125 billion across major global markets including the US, EU, China,... Read More
